Utility of a clinical risk score to identify high-risk patients with de novo acute myeloid leukaemia in first remission after high-dose cytarabine (HiDAC) based induction chemotherapy.
BRITISH JOURNAL OF HAEMATOLOGY（2013）
关键词
AML,cytogenetics of leukaemia,prognostic factors
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要